in News
DARPA Taps Sorrento for COVID-19 Rapid Countermeasure Effort
A subsidiary of Sorrento Therapeutics has landed a potential $34M contract from the Defense Advanced Research Projects Agency to produce a rapid countermeasure against COVID-19.